VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BNR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BNRBurning Rock Biotech Limited
$8.08$9M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBNRQuarterly Financials

Burning Rock Biotech Limited (BNR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Burning Rock Biotech Limited (BNR) quarterly income statement — complete revenue, gross profit & net income history

BNR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21
Sales/Revenue126.31M131.62M148.55M133.08M126.02M128.64M135.53M125.62M121.08M127.57M146.27M142.52M142.24M154.63M130.85M135.52M147.34M126.61M127.28M106.62M
Revenue Growth %0.23%2.31%9.61%5.94%4.08%0.85%-7.34%-11.85%-14.87%-17.5%11.79%5.16%-3.47%22.13%2.8%27.11%11.86%2.21%18.98%58.36%
Cost of Goods Sold27.75M32.77M40.45M35.68M36.6M36.8M40.09M39.93M42.97M41.65M45.85M43.74M40.97M46.04M48.24M47.94M41.97M35.02M37.05M29.68M
COGS % of Revenue21.97%24.9%27.23%26.81%29.04%28.6%29.58%31.78%35.49%32.65%31.34%30.69%28.81%29.77%36.87%35.38%28.48%27.66%29.11%27.84%
Gross Profit98.57M98.84M108.1M97.4M89.42M91.85M95.44M85.69M78.11M85.92M100.42M98.77M101.26M108.59M82.6M87.58M105.38M91.6M90.23M76.94M
Gross Margin %78.03%75.1%72.77%73.19%70.96%71.4%70.42%68.22%64.51%67.35%68.66%69.31%71.19%70.23%63.13%64.62%71.52%72.34%70.89%72.16%
Gross Profit Growth %10.23%7.62%13.27%13.66%14.48%6.9%-4.96%-13.24%-22.86%-20.88%21.57%12.78%-3.91%18.56%-8.46%13.83%6.28%0.01%15.09%71.8%
Operating Expenses110.6M114.97M119.6M112.58M171.35M130.44M206.65M211.52M244.44M264.74M236.15M287.23M318.71M343.24M348.06M350.44M357.51M262.64M292.26M248.8M
OpEx % of Revenue87.56%87.36%80.51%84.59%135.97%101.39%152.47%168.38%201.87%207.53%161.45%201.54%224.07%221.97%266.01%258.58%242.63%207.43%229.62%233.35%
Selling, General & Admin75.74M73.51M69.83M72.19M84.02M81.28M141.7M145.54M171.32M181.03M140.37M192.81M217.88M233.81M255.95M230.94M244.78M192.99M184.19M171.39M
SG&A % of Revenue59.96%55.85%47.01%54.25%66.67%63.19%104.55%115.85%141.49%141.91%95.97%135.29%153.18%151.2%195.61%170.41%166.13%152.42%144.71%160.74%
Research & Development34.87M41.47M49.77M40.39M52.2M49.15M64.95M65.98M73.12M83.7M95.78M94.42M100.83M109.43M92.11M119.5M112.72M69.65M108.07M77.41M
R&D % of Revenue27.6%31.51%33.5%30.35%41.42%38.21%47.92%52.53%60.39%65.61%65.48%66.25%70.89%70.77%70.4%88.17%76.5%55.01%84.91%72.61%
Other Operating Expenses00001000K0000-157K-118K599K-84K-189K127K298K-372K20K433K118K
Operating Income-12.04M-16.13M-11.5M-15.18M-81.93M-38.59M-111.22M-125.83M-166.32M-178.81M-135.72M-188.46M-217.44M-234.64M-265.46M-262.86M-252.13M-171.04M-202.03M-171.86M
Operating Margin %-9.53%-12.26%-7.74%-11.41%-65.01%-30%-82.06%-100.16%-137.36%-140.17%-92.79%-132.24%-152.87%-151.74%-202.88%-193.96%-171.11%-135.09%-158.73%-161.19%
Operating Income Growth %85.31%58.2%89.66%87.94%50.74%78.42%18.06%33.23%23.51%23.79%48.87%28.3%13.76%-37.18%-31.4%-52.95%-62.27%-37.22%-176.59%-189.61%
EBITDA9.72M-16.53M1.35M-13.28M-69.08M-5.73M-107.85M-92.97M-123.48M-148.63M-105.54M-158.27M-187.26M-223.49M-235.38M-251.71M-240.98M-162.93M-191.2M-163.75M
EBITDA Margin %7.7%-12.56%0.91%-9.98%-54.82%-4.45%-79.57%-74%-101.98%-116.51%-72.15%-111.06%-131.65%-144.53%-179.89%-185.73%-163.55%-128.68%-150.22%-153.58%
EBITDA Growth %114.07%-188.7%101.25%85.72%44.06%96.15%-2.19%41.26%34.06%33.5%55.16%37.12%22.29%-37.17%-23.11%-53.72%-63.64%-39.32%-192.41%-217.2%
D&A (Non-Cash Add-back)21.76M012.85M012.85M32.86M032.86M42.84M30.19M30.19M30.19M30.19M11.15M30.08M11.15M11.15M8.11M10.83M8.11M
EBIT-14.49M-16.53M-9.46M-13.28M-46.8M-35.54M-107.85M-121.37M-148.3M-174.53M-130.8M-184.83M-214.32M-231.48M-262.02M-261.39M-252.2M-169.69M-201.47M-171.86M
Net Interest Income1.49M1.73M2.23M2.58M1.81M3.17M3.19M4.04M5.54M4.02M5.25M3.14M2.84M2.01M2.66M1.95M937K591K116K277K
Interest Income1.5M1.74M2.23M2.58M1.81M3.17M3.19M4.04M5.54M4.02M5.25M3.14M2.84M2.01M2.69M1.95M1.03M958K681K787K
Interest Expense15K15K00000000000029K094K367K565K510K
Other Income/Expense-2.47M-415K2.04M1.9M5.95M3.04M3.37M4.46M5.18M4.28M4.93M3.63M3.12M3.16M3.41M1.47M-166K991K-11K452K
Pretax Income-14.51M-16.55M-9.46M-13.28M-75.98M-35.54M-107.85M-121.37M-161.14M-174.53M-130.8M-184.83M-214.32M-231.48M-262.05M-261.39M-252.29M-170.05M-202.04M-171.41M
Pretax Margin %-11.49%-12.57%-6.37%-9.98%-60.29%-27.63%-79.57%-96.61%-133.08%-136.82%-89.42%-129.69%-150.68%-149.7%-200.28%-192.87%-171.23%-134.31%-158.74%-160.76%
Income Tax876K212K244K224K5.31M201K190K180K1.07M450K445K422K1.9M084K0-1.15M424K1.63M0
Effective Tax Rate %-6.04%-1.28%-2.58%-1.69%-6.99%-0.57%-0.18%-0.15%-0.66%-0.26%-0.34%-0.23%-0.89%0%-0.03%0%0.46%-0.25%-0.8%0%
Net Income-15.39M-16.76M-9.7M-13.5M-81.29M-35.74M-108.04M-121.55M-162.21M-174.98M-131.24M-185.25M-216.22M-231.48M-262.14M-261.39M-251.14M-170.48M-203.66M-171.41M
Net Margin %-12.18%-12.73%-6.53%-10.14%-64.51%-27.79%-79.71%-96.76%-133.97%-137.17%-89.73%-129.99%-152.02%-149.7%-200.34%-192.87%-170.45%-134.64%-160.01%-160.76%
Net Income Growth %81.07%53.12%91.02%88.89%49.88%79.57%17.68%34.39%24.98%24.41%49.93%29.13%13.9%-35.79%-28.71%-52.49%-60.5%-34.1%-186.63%-226.05%
Net Income (Continuing)-15.39M-16.76M-9.7M-13.5M-81.29M-35.74M-108.04M-121.55M-162.21M-174.98M-131.24M-185.25M-216.22M-231.48M-262.14M-261.39M-251.14M-170.48M-203.66M-171.41M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-14.70-15.60-9.00-12.50-78.70-34.60-105.30-118.50-158.40-171.00-128.10-180.90-211.20-222.80-250.00-250.10-240.40-163.60-195.70-164.70
EPS Growth %81.32%54.91%91.45%89.45%50.32%79.77%17.8%34.49%25%23.25%48.76%27.67%12.15%-36.19%-27.75%-51.85%-59.52%-33.55%27.09%47.71%
EPS (Basic)-14.70-15.60-9.00-12.50-78.70-34.60-105.30-118.50-158.40-171.00-128.10-180.90-211.20-222.80-250.00-250.10-240.40-163.60-195.70-164.70
Diluted Shares Outstanding1.05M1.08M1.08M1.08M1.03M1.03M1.03M1.03M1.02M1.02M1.02M1.02M1.02M1.04M1.05M1.05M1.04M1.04M1.04M1.04M
Basic Shares Outstanding1.05M1.08M1.08M1.08M1.03M1.03M1.03M1.03M1.02M1.02M1.02M1.02M1.02M1.04M1.05M1.05M1.04M1.04M1.04M1.04M
Dividend Payout Ratio--------------------